NCT04163640

Ovarian Rejuvenation for Premature Ovarian Insufficiency and Poor Ovarian Response

Ovarian Rejuvenation Through Intra-ovarian Injection of Platelet Rich Plasma for Women With Premature Ovarian Insufficiency (POI) and Poor Ovarian Response (POR)

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 90 (actual)
• Sponsor: Reproductive Medicine Associates of New Jersey · Academic / Other
• Sex: Female
• Age: 18 Years – 38 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to perform a prospective randomized controlled trial seeking to characterize the effects of intra-ovarian injection of platelet rich plasma (PRP) on biomarkers of ovarian reserve as well as IVF outcomes in women with primary ovarian insufficiency (POI) and poor ovarian response (POR) who decline the use of an egg donor to establish a pregnancy.

Detailed description

Patients will be randomized to either receive the intra-ovarian PRP injection procedure or not. Regardless of randomization patients will be re-assessed at the same time points for ovarian reserve parameters. If antral follicles are detected at follow up, patients will undergo controlled ovarian hyperstimulation and a routine in vitro fertilization cycle as per protocol.

Conditions

• Ovarian Failure
• Infertility, Female

Interventions

Type	Name	Description
OTHER	intra-ovarian platelet rich plasma injection	patients will undergo a transvaginal intra-ovarian platelet rich plasma injection

Timeline

• Start date: 2020-02-24
• Primary completion: 2022-08-05
• Completion: 2023-07-21
• First posted: 2019-11-15
• Last updated: 2023-09-15

Locations

2 sites across 2 countries: United States, Turkey (Türkiye)